News & Updates

Show Multimedia Only

Stressful life events precede RA diagnosis in adult patients

15 Sep 2026

More than half of the patients with a newly diagnosed rheumatoid arthritis (RA) have experienced stressful life event in the year prior to their diagnosis, according to a study.

Stressful life events precede RA diagnosis in adult patients

15 Sep 2026

Gender, CRP, biologic use predict secukinumab effectiveness in patients with PsA

15 Sep 2026 by

Male sex, elevated C-reactive protein (CRP), lower number of previous biologic/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) used, and lower Health Assessment Questionnaire (HAQ) score are all predictive of treatment response in European patients with psoriatic arthritis (PsA) treated with secukinumab, a study has shown.

Gender, CRP, biologic use predict secukinumab effectiveness in patients with PsA

15 Sep 2026

Poor sleep quality ups mortality risk in patients with chronic respiratory diseases

15 Sep 2026

Patients with an overlap of chronic obstructive pulmonary disease (COPD) and asthma (ACO) show worse sleep than those with asthma but better than COPD patients, according to a study. Poor sleep quality may increase mortality risk.

Poor sleep quality ups mortality risk in patients with chronic respiratory diseases

15 Sep 2026

AI + mammography: A new gateway for CVD detection?

15 Sep 2026 by

A retrospective analysis presented at ESC 2026 demonstrates the ability of artificial intelligence (AI) to detect cardiovascular diseases (CVDs) from routine mammograms.

AI + mammography: A new gateway for CVD detection?

15 Sep 2026

Preoperative weight loss may be beneficial in women undergoing endometrial cancer surgery

15 Sep 2026

In women with obesity who are scheduled to undergo endometrial cancer surgery, a preoperative weight loss intervention is feasible, helping reduce weight and the incidence of postoperative complications, according to a study.

Preoperative weight loss may be beneficial in women undergoing endometrial cancer surgery

15 Sep 2026

$Explore the evidence for carvedilol in heart failure with reduced ejection fraction (HFrEF), with a focus on its demonstrated$

Explore the evidence for carvedilol in heart failure with reduced ejection fraction (HFrEF), with a focus on its demonstrated benefits in reducing mortality, hospitalization, and disease-related morbidity.

14 Sep 2026

Heart failure with reduced ejection fraction (HFrEF) remains a major cause of morbidity and mortality, with recurrent hospitalizations often marking a challenging phase in the patient journey. For patients, being discharged is not the end of their treatment journey. While discharge from the hospital represents an important milestone, long-term management is essential to reduce the risk of clinical deterioration and improve survival.¹Carvedilol, a beta-blocker recommended as part of guideline-directed treatment for heart failure. Guideline-directed medical therapy (GDMT) refers to the combination of evidence-based medicine recommended to improve outcomes for patients with HFrEF. Current treatment generally centers on four key pillars: an angiotensin receptor–neprilysin inhibitor (ARNi), a mineralocorticoid receptor antagonist (MRA), and a sodium-glucose cotransporter-2 inhibitor (SGLT2i) and a beta-blocker such as carvedilol. Together, these therapies work through different pathways to help reduce symptoms, slow disease progression, lower the risk of hospitalization, and improve survival.

Explore the evidence for carvedilol in heart failure with reduced ejection fraction (HFrEF), with a focus on its demonstrated benefits in reducing mortality, hospitalization, and disease-related morbidity.

14 Sep 2026

Healthy seniors get cardioprotective benefit with statins

14 Sep 2026 by

Use of statins in the primary prevention setting yields a substantial reduction in the risk of major cardiovascular events in community-dwelling adults at least 70 years of age, as shown in the STAREE trial.

Healthy seniors get cardioprotective benefit with statins

14 Sep 2026

Compound exposure to heat wave, SFAP elevates risk of CV deaths

14 Sep 2026

Individuals with multiple exposure to extreme heat and substantial fire-sourced air pollution (SFAP) are at greater risk of cardiovascular mortality than those with single exposures, a study has found.

Compound exposure to heat wave, SFAP elevates risk of CV deaths

14 Sep 2026

Financial toxicity adds to burden of cancer survivors in SG

14 Sep 2026 by

Financial toxicity (FT) exists and is not uncommon among adult cancer survivors, potentially contributing to further decline in quality of life (QoL), according to a Singapore study. Moreover, those of lower socioeconomic status are particularly at risk of FT.

Financial toxicity adds to burden of cancer survivors in SG

14 Sep 2026

SGLT-2 inhibitors may avert portal hypertensive complications, death in cirrhosis patients

14 Sep 2026

Use of SGLT-2 inhibitors among patients with cirrhosis helps prevent portal hypertensive complications and improve survival, suggests a study.

SGLT-2 inhibitors may avert portal hypertensive complications, death in cirrhosis patients

14 Sep 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Stressful life events precede RA diagnosis in adult patients

Stressful life events precede RA diagnosis in adult patients

Gender, CRP, biologic use predict secukinumab effectiveness in patients with PsA

Gender, CRP, biologic use predict secukinumab effectiveness in patients with PsA

Poor sleep quality ups mortality risk in patients with chronic respiratory diseases

Poor sleep quality ups mortality risk in patients with chronic respiratory diseases

AI + mammography: A new gateway for CVD detection?

AI + mammography: A new gateway for CVD detection?

Preoperative weight loss may be beneficial in women undergoing endometrial cancer surgery

Preoperative weight loss may be beneficial in women undergoing endometrial cancer surgery

Explore the evidence for carvedilol in heart failure with reduced ejection fraction (HFrEF), with a focus on its demonstrated benefits in reducing mortality, hospitalization, and disease-related morbidity.

Explore the evidence for carvedilol in heart failure with reduced ejection fraction (HFrEF), with a focus on its demonstrated benefits in reducing mortality, hospitalization, and disease-related morbidity.

Healthy seniors get cardioprotective benefit with statins

Healthy seniors get cardioprotective benefit with statins

Compound exposure to heat wave, SFAP elevates risk of CV deaths

Compound exposure to heat wave, SFAP elevates risk of CV deaths

Financial toxicity adds to burden of cancer survivors in SG

Financial toxicity adds to burden of cancer survivors in SG

SGLT-2 inhibitors may avert portal hypertensive complications, death in cirrhosis patients

SGLT-2 inhibitors may avert portal hypertensive complications, death in cirrhosis patients